Hemp and CBD Market Projected to Show Strong

New Post Public Reply Private Reply Replies (0) Message Board
Jerseyfish
1,419
Hemp and CBD Market Projected to Show Strong Growth
FinancialBuzz.com News Commentary

NEW YORK, September 26, 2017 /PRNewswire/ --

According to a report by Forbes, a new research by Brightfield Group projects that the hemp-derived cannabidiol (CBD) will be billion-dollar market in just three years. The market is estimated to grow at a 55% compound annual growth rate over the next five years. The research indicates that 64.5% of the total revenue in the market come from the online channels, followed by 17.8% at smoke shops. Dispensaries also played a major role, with 9% of the sales. Hemp CBD is sold in all 50 states. Chineseinvestors.com, Inc. (OTC: CIIX), CV Sciences, Inc. (OTC: CVSI), Terra Tech Corp. (OTC: TRTC), Cannabis Sativa, Inc. (OTC: CBDS), Rocky Mountain High Brands, Inc. (OTC: RMHB)

"One of the most surprising things we found during this research was how many companies are currently operating in the space, and how few of them are generating significant revenue," said Bethany Gomez, the Director of Research at Brightfield Group, according to an article by Forbes. "Essentially everyone is trying to do hemp, but only a handful are doing it well. It's seen as easy because it can be sold online but, with restrictions on traditional marketing, it is very difficult to connect with your core consumer and even communicate why they need your product."

Chineseinvestors.com, Inc. (OTCQB: CIIX) just announced breaking news this morning that, "it has appointed Paul Dickman as its Chief Financial Officer ("CFO" effective September 26, 2017. Mr. Dickman will also continue to serve on the Company's Board of Directors. As ChineseInvestors.com, Inc.'s new CFO, Mr. Dickman is responsible for leading financial operations and activities for the Company and establishing and monitoring the financial plan and strategies for the Company. Mr. Dickman previously served as the Company's CFO from July 2010 through October 22, 2016, when he resigned to pursue a new opportunity. Upon his resignation as CFO, Mr. Dickman continued to remain a part of the Company's leadership team serving as a non-employee member of the Board of Directors and as the chairman of several committees.

Mr. Dickman has a broad range of accounting and finance experience. He began his career working as an auditor and financial consultant with several regional accounting and consulting firms. His previous roles include working on large private and public organizations as well as fraud investigations and preparing complex business valuations. In addition to his work as CFO for Chineseinvestors.com, Inc., he has also served as the CFO for several other companies which he has led through the process of becoming publicly traded companies. Mr. Dickman is an entrepreneur and has successfully built businesses from the ground up, as well as being an active investor in the angel community. Mr. Dickman is also the founder and president of Breakwater MB, a boutique merchant bank focused on investing in high-growth businesses in emerging industries.

In addition to his work in finance, Mr. Dickman has extensive experience serving as a governance expert and board member. In addition to serving on the board of Chineseinvestors.com, Inc. he has served on the board of the Rockies Venture Club, Medicine Man Technologies, Inc. as well as a local nonprofit board. During his time serving in these, capacities he has continued to develop this expertise for which he was recognized as a Fellow of the National Association of Corporate Directors (NACD).

"We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer. We look forward to his contributions in the financial and contractual management of the Company's growth. Moreover, Paul shares our passion for excellence, innovation, and entrepreneurial thinking," said Warren Wang, Chief Executive Officer. "I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth."

"I am excited to resume the position as CFO for ChineseInvestors.com, Inc.," said Paul. "Over the next few years, we will work together to identify the greatest opportunities for growth and develop and adopt strategic solutions to achieve our growth goals for the upcoming year."

Paul received his Bachelor of Science in financial management from Bob Jones University. He is currently a licensed CPA in the state of South Carolina." About ChineseInvestors.com - Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.

CV Sciences, Inc. (OTCQB: CVSI), recently cited additional research suggesting cannabidiol (CBD) may be efficacious in preventing and treating drug addictions. A recent study conducted by researchers at the University of Mississippi and Elsohly Laboratories titled, "Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice" demonstrated that in a murine model of drug addiction, the administration of CBD at a dose of 10mg/kg was effective in blocking behavior rewarded with opioids (morphine).

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, announced on September 19th, that it has signed its second Craft Cultivator to grow the Company's proprietary high grade "IVXX" cannabis flowers and oils. The farm, Cultivar Inc., is located in Salinas, California and is approved for up to six acres (approximately 244,000 square feet) of cannabis cultivation, to be grown in high tech, climate-controlled greenhouses.

Medical Marijuana, Inc. (OTC: MJNA) mission is to be the premier cannabis and hemp industry innovators. On September 22nd, Medical Marijuana, Inc. portfolio company, Kannalife Sciences, Inc., a pharmaceutical and phyto-medical company, announced that former three time NFL Pro-Bowl and Kansas City Chiefs placekicker, Nick Lowery, has joined Kannalife corporate advisory board to lead the Company's initiative on speaking about chronic traumatic encephalopathy (CTE) and Kannalife's efforts to bring forth a clinically approved treatment for CTE. Kannalife Sciences holds the exclusive license from the federal government to commercialize a cannabinoid patent currently held by the U.S. Government and National Institutes of Health (NIH).

Cannabis Sativa, Inc. (OTCQB: CBDS) is engaged in the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. On August 2nd, the company announced the acquisition of a controlling interest in PrestoCorp (a.k.a. PrestoDoctor), an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology.

Rocky Mountain High Brands, Inc. (OTCQB: RMHB) is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water. On September, 2017, the company announced that its Board of Directors approved an increase in the authorized common stock to 4,000,000,000 shares.


Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading